نتائج البحث

Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab.

• Authors : Chida-Nagai A; Department of Pediatrics, Hokkaido University, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.; Sato H

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Palivizumab*/Palivizumab*/Palivizumab*/therapeutic use ; Premature Birth*

• Source: European journal of pediatrics [Eur J Pediatr] 2022 Feb; Vol. 181 (2), pp. 539-547. Date of Electronic Publication: 2021 Aug 21.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7603873 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants.

• Authors : Blanken MO; Frederix GW ...

Subjects: Cost-Benefit Analysis*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*economics ; Health Care Costs/Health Care Costs/Health Care Costs/*statistics & numerical data

• Source: European journal of pediatrics [Eur J Pediatr] 2018 Jan; Vol. 177 (1), pp. 133-144. Date of Electronic Publication: 2017 Nov 22.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7603873 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia.

• Authors : Piñeros JG; Santa Fe Foundation University Hospital, Bogota, DC, Colombia.; De la Hoz-Valle J

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Palivizumab/Palivizumab/Palivizumab/*administration & dosage ; Respiratory Syncytial Virus Infections/Respiratory Syncytial Virus Infections/Respiratory Syncytial Virus Infections/*prevention & control

• Source: Journal of infection in developing countries [J Infect Dev Ctries] 2021 Nov 30; Vol. 15 (11), pp. 1708-1713. Date of Electronic Publication: 2021 Nov 30.Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection.

• Authors : Antepowicz A; Gene Medicine Research Group, NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Habib O

Subjects: Gene Expression* ; Genetic Therapy* ; Respiratory Syncytial Viruses*/Respiratory Syncytial Viruses*/Respiratory Syncytial Viruses*/immunology

• Source: Scientific reports [Sci Rep] 2021 Aug 03; Vol. 11 (1), pp. 15694. Date of Electronic Publication: 2021 Aug 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders.

• Authors : Paes B; Kim D ...

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Palivizumab/Palivizumab/Palivizumab/*therapeutic use ; Respiratory Syncytial Virus Infections/Respiratory Syncytial Virus Infections/Respiratory Syncytial Virus Infections/*prevention & control

• Source: European journal of pediatrics [Eur J Pediatr] 2019 Mar; Vol. 178 (3), pp. 377-385. Date of Electronic Publication: 2019 Jan 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7603873 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

An epidemiological investigation of high-risk infants for Respiratory Syncytial Virus infections: a retrospective cohort study.

• Authors : Servadio, Michela^1,2 (AUTHOR); Finocchietti, Marco¹ (AUTHOR); Vassallo, Chiara² (AUTHOR)

• Source: Italian Journal of Pediatrics. 3/25/2024, Vol. 50 Issue 1, p1-14. 14p.

تفاصيل العنوان

Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: a systematic review of seven Italian reports.

• Authors : Cutrera R; Pediatric Pulmonology and Sleep & Long-Term Ventilation Unit, Pediatric Intermediate Care Unit, Academic Pediatric Department, Pediatric Hospital 'Bambino Gesù', Rome, Italy.; Wolfler A

Subjects: Health Care Costs*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hospitalization/Hospitalization/Hospitalization/*economics

• Source: Italian journal of pediatrics [Ital J Pediatr] 2019 Nov 09; Vol. 45 (1), pp. 139. Date of Electronic Publication: 2019 Nov 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101510759 Publication Model: Electronic Cited Medium: Internet ISSN: 1824-7288

تفاصيل العنوان

Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab.

• Authors : Permpalung N; a Department of Medicine , Beth Israel Deaconess Medical Center and Harvard Medical School , Boston , MA , USA.; Mahoney MV

Subjects: Hematologic Neoplasms/Hematologic Neoplasms/Hematologic Neoplasms/*therapy ; Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/*adverse effects ; Palivizumab/Palivizumab/Palivizumab/*adverse effects

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2019 Jan; Vol. 60 (1), pp. 85-91. Date of Electronic Publication: 2018 Jun 27.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Palivizumab use in infants with Down syndrome-report from the German Synagis™ Registry 2009-2016.

• Authors : Simon A; Department of Pediatric Oncology and Hematology, Children's Hospital Medical Center, University Hospital of Saarland, Homburg, Germany. .; Gehrmann S

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Down Syndrome/Down Syndrome/Down Syndrome/*complications ; Palivizumab/Palivizumab/Palivizumab/*therapeutic use

• Source: European journal of pediatrics [Eur J Pediatr] 2018 Jun; Vol. 177 (6), pp. 903-911. Date of Electronic Publication: 2018 Apr 12.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7603873 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Detection of ON1 and novel genotypes of human respiratory syncytial virus and emergence of palivizumab resistance in Lebanon.

• Authors : Abou-El-Hassan H; Department of Experimental Pathology, Immunology, and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.

Subjects: Drug Resistance, Viral*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Palivizumab/Palivizumab/Palivizumab/*pharmacology

• Source: PloS one [PLoS One] 2019 Feb 21; Vol. 14 (2), pp. e0212687. Date of Electronic Publication: 2019 Feb 21 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان